LEX Diagnostics, a leading innovator in molecular diagnostics, has submitted dual applications to the U.S. Food and Drug ...

LEX Diagnostics, a Cambridge Cluster innovator in molecular diagnostics, has submitted dual applications to the FDA seeking 510(k) clearance and CLIA Waiver status in the United States for its ...

A total of 186 respiratory sputum or bronchoalveolar lavage fluid specimens were collected and analyzed. The multiplex PCR-dipstick DNA chromatography assay was deployed for detection, while ...

The test is the last of three multiplex bloodstream infection panels that the firm has designed for its Liaison Plex molecular testing instrument.

The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

In January 2024, the TaqMan Multiplex Assay for quantitative PCR useful, was developed by Thermo Fisher. It allows for the concurrent detection of a variety of targets with high specificity and ...

Austin, May 28, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, the Multiplex Assay Market is set to witness unprecedented growth, reaching USD 8.84 billion by 2032 from USD 3.05 billion in ...

Austin, June 05, 2025 (GLOBE NEWSWIRE) -- Multiplex Assay Market Size & Growth Analysis: According to SNS Insider, the Multiplex Assay Market was valued at USD 3.05 billion in 2023 and is ...